Seroprevalence of Varicella-Zoster Virus in Korea

被引:19
|
作者
Choi, Won Suk [1 ]
Noh, Ji Yun [1 ]
Huh, Joong Yeon [1 ]
Jo, Yu Mi [1 ]
Lee, Jacob [2 ]
Song, Joon Young [1 ]
Kim, Woo Joo [1 ]
Cheong, Hee Jin [1 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea
[2] Hallym Univ, Sch Med, Dept Internal Med, Seoul, South Korea
关键词
varicella zoster virus; varicella; herpes zoster; seroprevalence; HERPES-ZOSTER; EPIDEMIOLOGY; POPULATION; ADULTS;
D O I
10.1002/jmv.21917
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Varicella-zoster virus (VZV) causes chickenpox and herpes zoster. Korea is assumed to have a high seroprevalence of VZV, although data are scant. A cross-sectional and age-stratified study was conducted to investigate the seroprevalence of VZV in different ages in the South Korean population. Four medical institutions were chosen in the southwestern area of Seoul in the vicinity of Gyeonggi-do. Serum samples were obtained at each institution from consenting patients during April-August, 2008. Anti-VZV IgG antibody was measured by an enzyme immunoassay. Of the 887 patients, 87.6% had anti-VZV IgG antibody. The prevalence of anti-VZV IgG antibody was 75% during the first 3 months after birth, but was only 13.6% 12 months after birth. Anti-VZV IgG antibody prevalence increased, first at 1-2 years of age, and then at 5-6 years of age. The seroprevalence rate exceeded 90% in subjects over 11 years of age. The results show that the seroprevalence of VZV is relatively high in the South Korean population. A study on the rate of varicella vaccination and the vaccine's efficacy in South Korea is warranted. J. Med. Virol. 82:2123-2126, 2010. (c) 2010 Wiley-Liss, Inc.
引用
收藏
页码:2123 / 2126
页数:4
相关论文
共 50 条
  • [31] Varicella-zoster virus spread
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (20): : 2429 - 2429
  • [32] Varicella-zoster virus and pregnancy
    Charlier, Caroline
    Le Mercier, Delphine
    Salomon, Laurent J.
    Ville, Yves
    Kermorvant-Duchemin, Elsa
    Frange, Pierre
    Postaire, Martine
    Lortholary, Olivier
    Lecuit, Marc
    Leruez-Ville, Marianne
    PRESSE MEDICALE, 2014, 43 (06): : 665 - 675
  • [33] INCUBATION OF VARICELLA-ZOSTER VIRUS
    MYERS, MG
    HIERHOLZER, WJ
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1984, 138 (12): : 1155 - 1156
  • [34] ANTIGENS OF VARICELLA-ZOSTER VIRUS
    BRUNELL, PA
    GRANAT, M
    GERSHON, AA
    JOURNAL OF IMMUNOLOGY, 1972, 108 (03): : 731 - &
  • [35] VARICELLA-ZOSTER VIRUS LATENCY
    CROEN, KD
    STRAUS, SE
    ANNUAL REVIEW OF MICROBIOLOGY, 1991, 45 : 265 - 282
  • [36] Varicella-Zoster Virus of the Eyelid
    Watson, Alison H.
    Homer, Natalie A.
    Somogyi, Marie B.
    JAMA OPHTHALMOLOGY, 2020, 138 (07) : 795 - 796
  • [37] Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany
    Miriam Wiese-Posselt
    Anette Siedler
    Annette Mankertz
    Andreas Sauerbrei
    Hartmut Hengel
    Ole Wichmann
    Christina Poethko-Müller
    BMC Infectious Diseases, 17
  • [38] ZOSTER AFTER EXPOSURE TO VARICELLA-ZOSTER VIRUS
    MORENS, DM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (12): : 1722 - 1723
  • [39] Varicella vaccine and infection with varicella-zoster virus
    Vázquez, M
    Shapiro, ED
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (05): : 439 - 440
  • [40] Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt
    Ibrahim, Enas G.
    Wahed, Wafaa Y. Abdel
    Eid, Hanaa M.
    Deeb, Wessam S.
    JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION, 2019, 94 (01): : 1 - 6